×
For best experience we recommend to activate Javascript in your browser.
KIR2DL3 antibody (AA 19-161)
The Mouse Monoclonal anti-KIR2DL3 antibody (Clone 190IIC311) (ABIN933927) specifically detects KIR2DL3 in WB, ELISA and FACS.
The antibody is reactive with Human samples.
Catalog No. ABIN933927
$1,157.24
Plus shipping costs $50.00
Delivery in 9 to 12 Business Days
Quick Overview for KIR2DL3 antibody (AA 19-161) (ABIN933927)
Target
See all KIR2DL3 Antibodies
KIR2DL3
(Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3 (KIR2DL3))
Reactivity
All reactivities for KIR2DL3 antibodies
Human
Host
All hosts for KIR2DL3 antibodies
Mouse
Clonality
All clonalities for KIR2DL3 antibodies
Monoclonal
Conjugate
All conjugates for KIR2DL3 antibodies
This KIR2DL3 antibody is un-conjugated
Application
All applications for KIR2DL3 antibodies
Western Blotting (WB), ELISA, Flow Cytometry (FACS)
Clone
190IIC311
Product Details anti-KIR2DL3 Antibody
(hide)
Binding Specificity
All epitopes for KIR2DL3 antibodies
AA 19-161
Purification
KIR2DL3 antibody was purified by protein-G affinity chromatography
Immunogen
KIR2DL3 antibody was raised in mouse using recombinant human KIR2DL3(19-161aa) purified from E. coli as the immunogen.
Isotype
IgG2a kappa
Alternatives
(show)
Application Details
(hide)
Application Notes
To be determiend by end-user.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
Lot specific
Buffer
as a liquid PBS, pH 7.4, with 0.1 % NaN3.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice
Avoid repeated freeze/thaw cycles
Storage
-20 °C
Storage Comment
Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
Target Details for KIR2DL3
(hide)
Target
KIR2DL3
(Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3 (KIR2DL3))
Alternative Name
KIR2DL3
Pathways
Cancer Immune Checkpoints
Recently viewed
(hide)
Chat with us , powered by LiveChat